BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34488188)

  • 1. Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells.
    Yan F; Wang X; Xie Y; Liu X; Yu L; Wang P; Li T; Wang S; Li W; Yang Z
    Phytomedicine; 2021 Oct; 91():153722. PubMed ID: 34488188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
    Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
    Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis.
    Yan F; Feng M; Wang X; Wang P; Xie Y; Liu X; Li W; Yang Z
    Cancer Cell Int; 2020 Nov; 20(1):540. PubMed ID: 33292207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria-Mediated Apoptosis and Enhancing Immune Function.
    Chen X; Cao Z; Zhang Y; Li J; Wang S; Du J; Liao L
    Integr Cancer Ther; 2017 Sep; 16(3):329-338. PubMed ID: 27335087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis.
    Yin Y; Wang Y; Wang C; Zhang Y; Qi A; Song J; Xu L; Yang W; Jiao L
    J Ethnopharmacol; 2024 May; 326():117984. PubMed ID: 38428661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responses.
    Zhang XS; Zhou HC; Wei P; Chen L; Ma WH; Ding L; Liang SC; Chen BD
    World J Gastrointest Oncol; 2023 Dec; 15(12):2138-2149. PubMed ID: 38173440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of Shiquanyuzhentang on immunologic function of H
    Zhu YC; Zhan GJ; Yuan DP; Yang FM; Huang Q
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jan; 33(1):51-55. PubMed ID: 29926607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysaccharides from Chinese Herbal
    Deng X; Luo S; Luo X; Hu M; Ma F; Wang Y; Lai X; Zhou L
    J Immunol Res; 2018; 2018():3431782. PubMed ID: 29967800
    [No Abstract]   [Full Text] [Related]  

  • 9. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol exerts antitumor effects by downregulating CD8
    Zhang Q; Huang H; Zheng F; Liu H; Qiu F; Chen Y; Liang CL; Dai Z
    Oncoimmunology; 2020 Oct; 9(1):1829346. PubMed ID: 33150044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Ciji-Hua'ai-Baosheng on immune function of mice with H
    Xi S; Fu B; Loy G; Minuk GY; Peng Y; Qiu Y; Zhai X; Wang Y; Li P; Gong Y; Wang J; Huang S; Lu D; Wang Y
    Biomed Pharmacother; 2018 May; 101():898-909. PubMed ID: 29635899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis.
    Li C; Wu X; Zhang H; Yang G; Hao M; Sheng S; Sun Y; Long J; Hu C; Sun X; Li L; Zheng J
    Tumour Biol; 2015 Mar; 36(3):1739-45. PubMed ID: 25374064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
    Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis.
    Li W; Tian YH; Liu Y; Wang Z; Tang S; Zhang J; Wang YP
    J Toxicol Sci; 2016; 41(3):417-28. PubMed ID: 27193733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative effect of Bifidobacteria lipoteichoic acid combined with 5-fluorouracil on hepatoma-22 cells growth and apoptosis.
    Guo B; Xie N; Wang Y
    Bull Cancer; 2015 Mar; 102(3):204-12. PubMed ID: 25747889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Tumor Effects of the Polysaccharide Isolated from Tarphochlamys Affinis in H22 Tumor-Bearing Mice.
    Tang X; Huang J; Xiong H; Zhang K; Chen C; Wei X; Xu X; Xie Q; Huang R
    Cell Physiol Biochem; 2016; 39(3):1040-50. PubMed ID: 27537353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice.
    Tian QE; Li HD; Yan M; Cai HL; Tan QY; Zhang WY
    World J Gastroenterol; 2012 Dec; 18(47):7079-86. PubMed ID: 23323011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8
    Zhang H; Zhang Y; Dong J; Zuo S; Meng G; Wu J; Wei J
    Cell Oncol (Dordr); 2021 Dec; 44(6):1243-1255. PubMed ID: 34491549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.